BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stapff MP. Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes. World J Diabetes 2018; 9(12): 252-257 [PMID: 30588287 DOI: 10.4239/wjd.v9.i12.252] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Canonico ME, Hsia J, Hess CN, Bonaca MP. Sex differences in guideline-directed medical therapy in 2021-22 among patients with peripheral artery disease. Vasc Med 2023;:1358863X231155308. [PMID: 36847166 DOI: 10.1177/1358863X231155308] [Reference Citation Analysis]
2 Canonico ME, Hsia J, Cannon CP, Bonaca MP. Uptake of Newer Guideline-Directed Therapies in Heart Failure Patients With Diabetes or Chronic Kidney Disease. JACC: Heart Failure 2022. [DOI: 10.1016/j.jchf.2022.09.013] [Reference Citation Analysis]
3 Muncan B, Abboud A, Papamanoli A, Jacobs M, McLarty AJ, Skopicki HA, Kalogeropoulos AP. Five-Year Cardiovascular Outcomes after Infective Endocarditis in Patients with versus without Drug Use History. J Pers Med 2022;12. [PMID: 36294701 DOI: 10.3390/jpm12101562] [Reference Citation Analysis]
4 Shafeek P, Clegg T, Kawmi N, Luciano S, Bone C, Graziane N. The temporal relationship between antibiotic and opioid prescription on the risk of developing an opioid use disorder: A national database study. J Addict Dis 2022;:1-8. [PMID: 35938745 DOI: 10.1080/10550887.2022.2108364] [Reference Citation Analysis]
5 Salmasi S, Yu OHY, Filion KB. Potential role of SGLT2 inhibitors in the management of hypertension. Trends Cardiovasc Med 2022:S1050-1738(22)00104-9. [PMID: 35835326 DOI: 10.1016/j.tcm.2022.07.002] [Reference Citation Analysis]
6 Dai H, Younis A, Kong JD, Puce L, Jabbour G, Yuan H, Bragazzi NL. Big Data in Cardiology: State-of-Art and Future Prospects. Front Cardiovasc Med 2022;9:844296. [DOI: 10.3389/fcvm.2022.844296] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pfaff ER, Girvin AT, Gabriel DL, Kostka K, Morris M, Palchuk MB, Lehmann HP, Amor B, Bissell M, Bradwell KR, Gold S, Hong SS, Loomba J, Manna A, McMurry JA, Niehaus E, Qureshi N, Walden A, Zhang XT, Zhu RL, Moffitt RA, Haendel MA, Chute CG, Adams WG, Al-Shukri S, Anzalone A, Baghal A, Bennett TD, Bernstam EV, Bernstam EV, Bissell MM, Bush B, Campion TR, Castro V, Chang J, Chaudhari DD, Chen W, Chu S, Cimino JJ, Crandall KA, Crooks M, Davies SJD, DiPalazzo J, Dorr D, Eckrich D, Eltinge SE, Fort DG, Golovko G, Gupta S, Haendel MA, Hajagos JG, Hanauer DA, Harnett BM, Horswell R, Huang N, Johnson SG, Kahn M, Khanipov K, Kieler C, Luzuriaga KR, Maidlow S, Martinez A, Mathew J, McClay JC, McMahan G, Melancon B, Meystre S, Miele L, Morizono H, Pablo R, Patel L, Phuong J, Popham DJ, Pulgarin C, Santos C, Sarkar IN, Sazo N, Setoguchi S, Soby S, Surampalli S, Suver C, Vangala UMR, Visweswaran S, Oehsen JV, Walters KM, Wiley L, Williams DA, Zai A; N3C Consortium. Synergies between centralized and federated approaches to data quality: a report from the national COVID cohort collaborative. J Am Med Inform Assoc 2022;29:609-18. [PMID: 34590684 DOI: 10.1093/jamia/ocab217] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
8 Franco BN, Asano S. COVID-19-Related Trends and Characteristics of Type 2 Diabetes Mellitus and Metabolic Syndrome. Cureus 2022. [DOI: 10.7759/cureus.21483] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Clegg TJ, Kawmi N, Graziane NM. Different classes of antibiotics have varying effects on the risk of developing opioid use disorder: a national database study. Journal of Substance Use. [DOI: 10.1080/14659891.2021.2010140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Trager RJ, Mok SRS, Schlick KJ, Perez JA, Dusek JA. Association between radicular low back pain and constipation: a retrospective cohort study using a real-world national database. Pain Rep 2021;6:e954. [PMID: 34476303 DOI: 10.1097/PR9.0000000000000954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Freedman ZG, Kane JA, King TS, Graziane NM. The effect of prescribing antibiotics with opioids on the development of opioid use disorder: a national database study. J Addict Dis 2021;:1-13. [PMID: 34030608 DOI: 10.1080/10550887.2021.1926889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Masurkar PP, Chatterjee S, Sherer JT, Aparasu RR. Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia. Drugs Aging 2021;38:593-602. [PMID: 34027602 DOI: 10.1007/s40266-021-00863-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Krogh J, Hjorthøj C, Kristensen SL, Selmer C, Haugaard SB. The effect of sodium-glucose transport protein 2 inhibitors on mortality and heart failure in randomized trials versus observational studies. Diabet Med 2021;38:e14600. [PMID: 33991127 DOI: 10.1111/dme.14600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Baillargeon J, Polychronopoulou E, Kuo YF, Raji MA. The Impact of Substance Use Disorder on COVID-19 Outcomes. Psychiatr Serv 2021;72:578-81. [PMID: 33138712 DOI: 10.1176/appi.ps.202000534] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 29.0] [Reference Citation Analysis]
15 Tecson KM, Shafiei SS. Pharmacoepidemiology in Cardiorenal Medicine. Textbook of Cardiorenal Medicine 2021. [DOI: 10.1007/978-3-030-57460-4_24] [Reference Citation Analysis]
16 Harrison PJ, Luciano S, Colbourne L. Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: An electronic health records network study. J Psychopharmacol 2020;34:848-55. [PMID: 32638634 DOI: 10.1177/0269881120936501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
17 Manceur AM, Durkin M, Kharat A, Bookhart B, Lafeuille MH, Pilon D, Fakih I, Lefebvre P. Costs associated with renal and cardiovascular events among patients with type 2 diabetes mellitus and nephropathy: a cost model based on the CREDENCE clinical trial. Curr Med Res Opin 2020;36:563-70. [PMID: 31916465 DOI: 10.1080/03007995.2019.1708285] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
18 Batel-Marques F, Pereira D, Mendes D, Alves C, Penedones A. Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic review. BMJ Open 2019;9:e032522. [PMID: 31530624 DOI: 10.1136/bmjopen-2019-032522] [Reference Citation Analysis]